WASH:NASDAQWashington Trust Bancorp, Inc. Analysis
Data as of 2026-07-30 - not real-time
$39.23
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Washington Trust Bancorp (WASH) is trading at $39.23, comfortably above its 20‑day (≈$36.99) and 50‑day (≈$35.18) SMAs and just shy of the calculated resistance of $39.85, signaling a strong short‑term bullish bias. The RSI of 63.9 and a bullish MACD histogram (+0.19) reinforce momentum, while volume is on an increasing trend, suggesting continued buying pressure. The latest Q2 2026 results showed revenue up 11% YoY to $60.47 M and GAAP EPS of $0.83, beating consensus by 7.9%, providing fresh earnings tailwinds. The bank’s profitability remains robust with a 25% profit margin and operating margin above 36%, and its forward PE of 11.1 is well below the industry average of 17.9, indicating relative cheapness. A dividend yield of 5.66% and a payout ratio near 78% make the stock attractive for income seekers, though the high payout warrants monitoring. However, a 30‑day volatility of 33.5% and a max drawdown of –18.4% highlight notable price swings, while a beta of 0.78 suggests moderate market sensitivity. Analyst consensus is neutral (hold) with a median target of $37, implying a modest downside of about 3% from current levels. Overall, the blend of solid earnings, attractive valuation metrics, and a high dividend is offset by elevated volatility and sector‑specific credit and regulatory concerns.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Recent earnings beat and revenue growth
- Proximity to technical resistance at $39.85
- High dividend yield supporting demand
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Undervalued PE relative to industry peers
- Sustained operating margins above 35%
- Moderate beta and improving cash position
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Attractive dividend yield with reasonable payout ratio
- Blend of growth (10% revenue rise) and value (low forward PE)
- Strong balance sheet fundamentals despite sector risk
Key Metrics & Analysis
Financial Health
Revenue Growth9.70%
Profit Margin25.07%
P/E Ratio13.6
ROE10.25%
ROA0.83%
P/B Ratio1.4
Industry P/E17.9
Technical Analysis
TrendBullish
RSI64.0
Support$34.69
Resistance$39.85
MA 20$36.99
MA 50$35.18
MA 200$32.22
MACDBullish
VolumeIncreasing
Fear & Greed Index84.54
Valuation
Target Price$38.00
Upside/Downside-3.14%
GradeFair
TypeBlend
Dividend Yield5.66%
Risk Assessment
Beta0.78
Volatility33.54%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.